Skip to main content
Clinical Trials/NCT02718456
NCT02718456CompletedNot Applicable

Overcoming Barriers to HIV/AIDS Care and ART Initiation

University of Washington1 site in 1 country315 target enrollmentStarted: August 1, 2013Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
315
Locations
1
Primary Endpoint
Number of days from study enrollment until first visit to a comprehensive care center for HIV care.

Study Overview

Brief Summary

The study will evaluate interventions to improve engagement in HIV care following HIV diagnosis through a voluntary counseling and testing program. The specific aims are to (1) determine if a VCT-based intervention of CD4 count testing, alone or in combination with peer counseling, improves linkage to HIV/AIDS care; (2) assess the impact of the intervention on ART initiation. The study will recruit 450 HIV-positive individuals from VCTs and randomize a third to standard counseling and referral, a third to receive CD4 testing at the VCT with results return by phone after 1 weeks, and a third to receive the same CD4 testing combined with peer counseling. These combined investigations will create a comprehensive understanding of obstacles to appropriate HIV/AIDS care and result in new interventions to achieve measurable outcomes in applied settings.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Health Services Research
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •At least 18 years or older and
  • •Testing HIV-positive for the first time at a voluntary counseling and testing (VCT) center.
  • •Willing to receive counseling to encourage linkage to care at a comprehensive care center (CCC).
  • •Willing to have a CD4 count test conducted at the enrollment visit.
  • •Willing to have a telephone follow-up where they may receive additional counseling and/or have their CD4 count results returned to them.
  • •Willing to be contacted over 1 year to determine if they linked to care.

Exclusion Criteria

  • •Previous positive HIV test.
  • •Currently taking antiretroviral medications.
  • •Currently pregnant (females only).
  • •Currently participating in another research study or trial.
  • •Not planning to remain in Nairobi for the next 12 months (not including short trips out of Nairobi).

Arms & Interventions

Standard of care

No Intervention

Standard HIV counseling and referral to care

CD4 testing

Experimental

Standard HIV counseling and testing plus blood drawn for CD4 testing at time of HIV diagnosis. CD4 results are reported to participants via telephone within 1 week.

Intervention: Expedited CD4 testing (Behavioral)

CD4 testing plus peer counseling

Experimental

Standard HIV counseling and testing plus blood drawn for CD4 testing at time of HIV diagnosis. CD4 results are reported to participants via telephone within 1 week. Additionally, a trained peer counselor provides supplemental counseling at the time of diagnosis and at the 1 week telephone follow-up.

Intervention: Expedited CD4 testing (Behavioral)

CD4 testing plus peer counseling

Experimental

Standard HIV counseling and testing plus blood drawn for CD4 testing at time of HIV diagnosis. CD4 results are reported to participants via telephone within 1 week. Additionally, a trained peer counselor provides supplemental counseling at the time of diagnosis and at the 1 week telephone follow-up.

Intervention: Supplemental peer counseling (Behavioral)

Outcomes

Primary Outcomes

Number of days from study enrollment until first visit to a comprehensive care center for HIV care.

Time Frame: 1 year

An interviewer administered questionnaire will be used to determine if each participant visited a comprehensive care center. Is so, the date of the first visit will be recorded. From this, the time from enrollment until first visit to a comprehensive care center will be calculated.

Number of days from study enrollment until initiation of antiretroviral therapy.

Time Frame: 1 year

An interviewer administered questionnaire will be used to determine if each participant started antiretroviral therapy. Is so, the date of treatment initiation will be recorded. From this, the time from enrollment until treatment initiation will be calculated.

Secondary Outcomes

  • Interviewer-administered questionnaire to determine the number of visits made to a comprehensive care center for HIV care.(1 year)
  • Measurement of CD4+ T-cell count.(1 year)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Brandon Guthrie

Assistant Professor, Global Health

University of Washington

Study Sites (1)

Loading locations...

Similar Trials